BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38342094)

  • 1. Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia.
    Zhong T; Xu D; Li W
    Acta Haematol; 2024 Feb; ():. PubMed ID: 38342094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.
    Gu M; Hao X; Cong L; Sun J
    Medicine (Baltimore); 2019 Dec; 98(50):e18196. PubMed ID: 31852076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients.
    Ding T; Wang X; Fu A; Xu L; Lin J
    Medicine (Baltimore); 2019 Oct; 98(43):e17314. PubMed ID: 31651837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.
    Hao A; Huang J; Xu X
    Ir J Med Sci; 2021 Aug; 190(3):1155-1164. PubMed ID: 33140294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive patient's care program reduces anxiety and depression as well as improves overall survival in
    Bao H; Chen Y; Li M; Pan L; Zheng X
    Transl Cancer Res; 2019 Feb; 8(1):212-227. PubMed ID: 35116750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients.
    Liu X; Zhan G
    Psychol Health Med; 2023; 28(9):2474-2485. PubMed ID: 37271963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung's Self-rating Anxiety Scale/Depression Scale.
    Cheng L; Gao W; Xu Y; Yu Z; Wang W; Zhou J; Zang Y
    Rheumatol Adv Pract; 2023; 7(3):rkad100. PubMed ID: 38033365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency.
    Deng L; Chen B
    Ir J Med Sci; 2023 Dec; 192(6):2613-2619. PubMed ID: 36826710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.
    Li J; Ma C
    Ir J Med Sci; 2023 Dec; 192(6):2621-2629. PubMed ID: 36862310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.
    Zhou L; Sun H
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101511. PubMed ID: 33713979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients.
    Wu X; Wang D; Wang D
    Front Surg; 2022; 9():1069709. PubMed ID: 36726957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia.
    Xue H; Gao H; Xia H; Li S; Li N; Gao C; Duan Y; Ren Y; Zhang H; Liu J; Gao W
    J Clin Lab Anal; 2021 Apr; 35(4):e23739. PubMed ID: 33704838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients.
    Qi X; Zhang Y
    Pediatr Hematol Oncol; 2022 Sep; 39(6):500-507. PubMed ID: 35044282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative anxiety and depression in surgical gastric cancer patients: their longitudinal change, risk factors, and correlation with survival.
    Liu P; Wang Z
    Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
    Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of Anxiety and Depression During a 3-Year Period as Well as Their Risk Factors and Prognostic Value in Postoperative Bladder Cancer Patients.
    Guo M; Li Y; Wang W; Kang X; Chen G
    Front Surg; 2022; 9():893249. PubMed ID: 35928029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal change and prognostic value of anxiety and depression in coronary heart disease patients.
    Wang D; Dai F; Liu W; Ge L; Qi X; Ma G
    Ir J Med Sci; 2021 Feb; 190(1):107-116. PubMed ID: 32661829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients.
    Ke S; Zhang X; Xiang X; Lu Y; An H
    Int J Lab Hematol; 2022 Apr; 44(2):342-348. PubMed ID: 34729939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.